What is omega-3? A plain-English guide
Omega-3s are fats in oily fish, algae and some plants. In a review of adult trials with varied heart risk, more EPA and DHA lowered blood triglycerides by about 15%. Reviews found little or no effect on overall thinking skills. Heart trials linked supplements to a higher risk of irregular heartbeat, more so at higher doses.
By the NootropicsWork Editorial Team. A plain-English guide, 5 minute read.
Bottom line
Omega-3s are fats in oily fish, algae and some plants. In a review of adult trials with varied heart risk, more EPA and DHA lowered blood triglycerides by about 15%. Reviews found little or no effect on overall thinking skills. Heart trials linked supplements to a higher risk of irregular heartbeat, more so at higher doses.
- In a Cochrane review of 86 adult trials, more EPA and DHA lowered blood triglycerides by about 15%, and the effect grew with the dose [1].
- Reviews of trials in adults found little or no effect of omega-3 on overall thinking skills [3][4], and results for memory are mixed [4][5].
- In heart trials, omega-3 supplements were linked to a higher risk of atrial fibrillation, more so in trials using more than 1 g a day [8].
For every study, dose and grade, read our full research summary on Omega-3 (DHA and EPA).
What is omega-3?
Omega-3s are a family of fats that people get from food [1]. The two main long-chain forms are EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), which come from oily fish [1]. A third form, ALA (alpha-linolenic acid), comes from plants [1].
EFSA, the European Food Safety Authority, lists fish, fish oils, milk and farmed sea algae as food sources [10]. It says adults in the EU eat on average up to 400 to 500 mg a day from food [10].
The body can turn some plant ALA into EPA, but a review found this is limited in men [2]. Very little goes on to become DHA [2]. Women turn more ALA into these longer forms than men do [2].
What do people use omega-3 for?
The authors of one large review say many older adults take omega-3 hoping to keep their thinking sharp [3]. Researchers have studied omega-3 for overall thinking skills [3][4], for memory [4][5] and for blood triglycerides [1].
What does the research show?
Does omega-3 help overall thinking skills?
Evidence grade for global cognition: N, no benefit shown. Why this grade
Reviews of trials found no clear effect. A meta-analysis is a study that pools the results of many trials. One meta-analysis pooled 25 randomized controlled trials, which are studies where people are split by chance into groups [4]. The adults in it did not have dementia, and some had mild cognitive impairment, a milder problem with memory and thinking [4]. It found no effect on overall thinking skills [4].
A larger meta-analysis pooled 38 trials with 49,757 adults, who were mostly older [3]. It found that EPA and DHA probably have little or no effect on new memory and thinking problems [3]. The World Health Organization paid for that review [3].
Single trials in healthy adults are mixed. In a 6-month trial in 193 healthy adults aged 20 to 80, 2.5 g a day did not improve test scores [6]. That trial compared omega-3 with a placebo, a dummy pill [6]. Our full research summary also covers a trial with a different result. A company that sells omega-3 ingredients paid for it.
Does omega-3 help memory?
Evidence grade for memory: C, limited. Why this grade
The evidence is mixed. The 25-trial meta-analysis found a mild benefit for memory [4]. Its authors said this benefit applied to older adults without dementia [4].
An earlier meta-analysis pooled 10 placebo-controlled trials [5]. It found no effect on overall memory scores [5]. That review included healthy adults, people with milder memory and thinking problems, and people with Alzheimer's disease [5].
The two reviews pooled different trials and different groups of people [4][5].
Does omega-3 lower blood triglycerides?
Evidence grade for blood triglycerides: A, strong. Why this grade
In trials, yes. A Cochrane review pooled 86 randomized trials with 162,796 people, and each trial lasted at least 12 months [1]. Getting more EPA and DHA lowered triglycerides by about 15% [1]. The effect grew as the dose went up [1].
The reviewers rated this finding as high-certainty evidence [1]. People in these trials had a range of heart risk, so they were not all healthy adults [1]. The UK Medical Research Council paid for the review [1].
To learn what each grade means, see how we grade evidence.
How much did studies use?
Table: Doses used in studies (not a recommendation)
| What was studied | Doses used in studies | Source |
|---|---|---|
| Overall thinking skills, healthy adults aged 20 to 80 (no effect found) | 2.5 g a day for 6 months | [6] |
| Blood triglycerides (range across all trials in the review) | 0.5 g to more than 5 g a day, for at least 12 months | [1] |
These are amounts used in research, not advice for any reader. In 2012, EFSA found that extra EPA and DHA of up to 5 g a day combined raised no safety concerns for adults [10]. It said the data were not enough to set an upper limit [10]. A 2021 analysis of heart trials linked omega-3 supplements to a higher risk of atrial fibrillation, more so above 1 g a day [8]. Talk to a clinician about your own situation.
Is omega-3 safe?
A meta-analysis of 90 trials looked at side effects [7]. People taking omega-3 had higher odds of diarrhea, changes in taste and a tendency to bleed than people on a placebo [7]. The review found no report of serious side effects clearly caused by omega-3 [7]. The Cochrane review found little or no effect on serious side effects [1].
Sources differ on bleeding. Unlike the 90-trial review, EFSA found in 2012 that up to 5 g a day did not raise reported bleeding in adults [10].
One warning sign in the research is atrial fibrillation, a type of irregular heartbeat [8]. A meta-analysis pooled 7 heart trials with 81,210 adults, whose average age was 65 [8]. In those trials, supplements were linked to a higher risk [8]. The rise was larger in trials using more than 1 g a day than in trials using less [8]. Our full research summary covers a newer analysis that differs on lower doses.
The Cochrane review looked at a wider group of heart rhythm problems and found little or no effect [1]. The reviewers had low confidence in that result [1].
One case report describes a woman taking warfarin, a blood thinner [9]. A blood-clotting test result rose after she doubled her fish oil from 1000 to 2000 mg a day [9]. It fell again after she cut back [9]. A single case cannot show that the fish oil caused the change. Our full research summary covers other warfarin studies.
Who should be careful with omega-3?
The research points to two groups:
- Adults like those in heart trials (average age 65). In one analysis, the risk rose in both dose groups, more so above 1 g a day [8].
- People who take a blood thinner, such as warfarin. One case report links a rise in a blood-clotting test to a higher fish oil dose [9].
As of November 12, 2026, the sources we checked do not name pregnancy, breastfeeding or children as groups who should avoid or limit omega-3 supplements. They are the reviews cited here, EFSA and an archived copy of the NIH Office of Dietary Supplements fact sheet.
If you take a blood thinner, such as warfarin, talk to your doctor or pharmacist before combining it with omega-3.
Want the full picture?
The full summary covers a memory trial in young adults who eat little DHA. It also covers other medicine interactions and legal status in four countries. Read it at Omega-3: full research summary.
Grades for the outcomes on this page, from the Omega-3 (DHA and EPA) research summary. They update when the evidence does.
| Outcome | Grade | Basis | Modifiers | Rationale |
|---|---|---|---|---|
| Global cognition | N No benefit shown, no effect found | Adequate human RCTs (several meta-analyses, including a Cochrane review, and large RCTs) found no meaningful effect | Why N grade for Global cognition: explainedApproved of the Global cognition grade | |
| Memory | C Limited | Results mainly in older adults with memory complaints being extrapolated to healthy adults, plus one RCT in young adults with low DHA intake; pooled estimates mixed | Why C grade for Memory: explainedApproved of the Memory grade | |
| Blood triglycerides | A Strong | >=1 meta-analysis (Cochrane, 86 RCTs) with consistent, dose-dependent direction, high-certainty evidence, at doses legally available | Why A grade for Blood triglycerides: explainedApproved of the Blood triglycerides grade |
References
- Abdelhamid AS, Brown TJ, Brainard JS, et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2020.
- Burdge GC, Calder PC. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev. 2005.
- Brainard JS, Jimoh OF, Deane KHO, et al. Omega-3, Omega-6, and Polyunsaturated Fat for Cognition: Systematic Review and Meta-analysis of Randomized Trials. J Am Med Dir Assoc. 2020.
- Alex A, Abbott KA, McEvoy M, et al. Long-chain omega-3 polyunsaturated fatty acids and cognitive decline in non-demented adults: a systematic review and meta-analysis. Nutr Rev. 2020.
- Mazereeuw G, Lanctôt KL, Chau SA, et al. Effects of ω-3 fatty acids on cognitive performance: a meta-analysis. Neurobiol Aging. 2012.
- Maltais M, Lorrain D, Léveillé P, et al. Long-chain Omega-3 fatty acids supplementation and cognitive performance throughout adulthood: A 6-month randomized controlled trial. Prostaglandins Leukot Essent Fatty Acids. 2022.
- Chang JP, Tseng PT, Zeng BS, et al. Safety of Supplementation of Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Adv Nutr. 2023.
- Gencer B, Djousse L, Al-Ramady OT, et al. Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. Circulation. 2021.
- Buckley MS, Goff AD, Knapp WE. Fish oil interaction with warfarin. Ann Pharmacother. 2004.
- European Food Safety Authority. EFSA assesses safety of long-chain omega-3 fatty acids. Updated July 27, 2012.